Stable marking and transgene expression without progression to monoclonality in canine long-term hematopoietic repopulating cells transduced with lentiviral vectors

Human Gene Therapy

Volumn 21, Issue 4, 2010, Pages 397-403

  Enssle, Joerg ^a   Trobridge, Grant D ^a,b   Keyser, Kirsten A ^a   Ironside, Christina ^a   Beard, Brian C ^a   Kiem, Hans Peter ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CEP1 PROTEIN; DST PROTEIN; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; PROTEIN; RAP1GDS1 PROTEIN; UNCLASSIFIED DRUG; WHSC1L1 PROTEIN; YELLOW FLUORESCENT PROTEIN; ZNF198 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD CELL; BONE MARROW CELL; CELL LINEAGE; CLONAL VARIATION; CONTROLLED STUDY; DOG; ERYTHROCYTE; FOLLOW UP; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA; LYMPHOID CELL; MONOCLONALITY; NONHUMAN; POLYMERASE CHAIN REACTION; STABLE EXPRESSION; THROMBOCYTE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIGENS, CD34; BACTERIAL PROTEINS; CELL LINEAGE; DOGS; FLOW CYTOMETRY; GENE THERAPY; GENETIC VECTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; LENTIVIRUS; LUMINESCENT PROTEINS; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSGENES;

ANIMALIA; CANIS FAMILIARIS; LENTIVIRUS;

EID: 77950929272     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.076     Document Type: Article

References (25)

1. Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., Marinello, E., Cattaneo, F., Vai, S., Servida, P., Miniero, R., Roncarolo, M.G., and Bordignon, C. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410-2413.
2. An, D.S., Kung, S.K., Bonifacino, A., Wersto, R.P., Metzger, M.E., Agricola, B.A., Mao, S.H., Chen, I.S., and Donahue, R.E. (2001). Lentivirus vector-mediated hematopoietic stem cell gene transfer of common g-chain cytokine receptor in rhesus macaques. J. Virol. 75, 3547-3555.
3. Baum, C., Von Kalle, C., Staal, F.J., Li, Z., Fehse, B., Schmidt, M., Weerkamp, F., Karlsson, S., Wagemaker, G., and Williams, D.A. (2004). Chance or necessity? Insertional mutagenesis in gene therapy and its consequences [review]. Mol. Ther. 9, 5-13.
4. Beagles, K.E., Peterson, L., Zhang, X., Morris, J., and Kiem, H.-P. (2005). Cyclosporine inhibits the development of green fluorescent protein (GFP)-specific immune responses after transplantation of GFP-expressing hematopoietic repopulating cells in dogs. Hum. Gene Ther. 16, 725-733.
5. Beard, B.C., Dickerson, D., Beebe, K., Gooch, C., Fletcher, J., Okbinoglu, T., Miller, D.G., Jacobs, M.A., Kaul, R., Kiem, H.-P., and Trobridge, G.D. (2007a). Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells. Mol. Ther. 15, 1356-1365.
6. Beard, B.C., Keyser, K.A., Trobridge, G.D., Peterson, L.J., Miller, D.G., Jacobs, M., Kaul, R., and Kiem, H.-P. (2007b). Unique integration profiles in a canine model of long-term re-populating cells transduced with gammaretrovirus, lentivirus, and foamy virus. Hum. Gene Ther. 18, 423-434.
7. Cockrell, A.S., and Kafri, T. (2007). Gene delivery by lentivirus vectors [review]. Mol. Biotechnol. 36, 184-204.
8. Edelstein, M.L., Abedi, M.R., and Wixon, J. (2007). Gene therapy clinical trials worldwide to 2007: An update [review]. J. Gene Med. 9, 833-842.
9. Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.P., Thrasher, A.J., Wulffraat, N., Sor-ensen, R., Dupuis-Girod, S., Fischer, A., Davies, E.G., Kuis, W., Leiva, L., and Cavazzana-Calvo, M. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185-1193. (Pubitemid 34984579)
10. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J.I., De Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Ma-cintyre, E., Sigaux, F., Soulier, J., Leiva, L.E., Wissler, M., Prinz, C., Rabbitts, T.H., Le Deist, F., Fischer, A., and Cavazzana-Calvo, M. (2003a). LMO2-associated clonal T cell proliferation
11. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.L., Fraser, C.C., Cavazzana-Calvo, M., and Fischer, A. (2003b). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255-256.
12. Hacein-Bey-Abina, S., Garrigue, A., Wang, G.P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., Asnafi, V., Macintyre, E., Dal Cortivo, L., Rad-ford, I., Brousse, N., Sigaux, F., Moshous, D., Hauer, J., Bork-hardt, A., Belohradsky, B.H., Wintergerst, U., Velez, M.C., Leiva, L., Sorensen, R., Wulffraat, N., Blanche, S., Bushman, F.D., Fischer, A., and Cavazzana-Calvo, M. (2008). Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118, 3132-3142.
13. Horn, P.A., Morris, J.C., Bukovsky, A.A., Andrews, R.G., Nal-dini, L., Kurre, P., and Kiem, H.-P. (2002). Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons. Gene Ther. 9, 1464-1471.
14. Horn, P.A., Keyser, K.A., Peterson, L.J., Neff, T., Thomasson, B.M., Thompson, J., and Kiem, H.-P. (2004). Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol. Blood 103, 3710-3716.
15. Howe, S.J., Mansour, M.R., Schwarzwaelder, K., Bartholomae, C., Hubank, M., Kempski, H., Brugman, M.H., Pike-Overzet, K., Chatters, S.J., De Ridder, D., Gilmour, K.C., Adams, S., Thornhill, S.I., Parsley, K.L., Staal, F.J., Gale, R.E., Linch, D.C., Bayford, J., Brown, L., Quaye, M., Kinnon, C., Ancliff, P., Webb, D.K., Schmidt, M., Von Kalle, C., Gaspar, H.B., and Thrasher, A.J. (2008). Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest. 118, 3143-3150.
16. Kustikova, O.S., Schiedlmeier, B., Brugman, M.H., Stahlhut, M., Bartels, S., Li, Z., and Baum, C. (2009). Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis. Mol. Ther. 17, 1537-1547.
17. Lowe, T., Bhatia, S., and Somlo, G. (2007). Second malignancies after allogeneic hematopoietic cell transplantation [review]. Biol. Blood Marrow Transplant. 13, 1121-1134.
18. Maruggi, G., Porcellini, S., Facchini, G., Perna, S.K., Cattoglio, C., Sartori, D., Ambrosi, A., Schambach, A., Baum, C., Bonini, C., Bovolenta, C., Mavilio, F., and Recchia, A. (2009). Transcrip-tional enhancers induce insertional gene deregulation independently from the vector type and design. Mol. Ther. 17, 851-856.
19. Moreno-Carranza, B., Gentsch, M., Stein, S., Schambach, A., Santilli, G., Rudolf, E., Ryser, M.F., Haria, S., Thrasher, A.J., Baum, C., Brenner, S., and Grez, M. (2009). Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells. Gene Ther. 16, 111-118.
20. Ott, M.G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kuhlcke, K., Schilz, A., Kunkel, H., Naundorf, S., Brinkmann, A., Deichmann, A., Fischer, M., Ball, C., Pilz, I., Dunbar, C., Du, Y., Jenkins, N.A., Copeland, N.G., Luthi, U., Hassan, M., Thrasher, A.J., Hoelzer, D., Von Kalle, C., Seger, R., and Grez, M. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12, 401-409.
21. Rethwilm, A. (2007). Foamy virus vectors: An awaited alternative to gammaretro-and lentiviral vectors [review]. Curr. Gene Ther. 7, 261-271.
22. Schmidt, M., Schwarzwaelder, K., Bartholomae, C., Zaoui, K., Ball, C., Pilz, I., Braun, S., Glimm, H., and Von Kalle, C. (2007). High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat. Methods 4, 1051-1057.
23. Stocking, C., and Baum, C. (1997). Gene transfer into haemo-poietic cells [review]. Baillieres Clin. Haematol. 10, 445-465.
24. Trobridge, G., Beard, B.C., and Kiem, H.-P. (2005). Hemato-poietic stem cell transduction and amplification in large animal models. Hum. Gene Ther. 16, 1355-1366.
25. Zhang, X.-B., Beard, B.C., Trobridge, G.D., Wood, B.L., Sale, G.E., Sud, R., Humphries, R.K., and Kiem, H.-P. (2008). High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector. J. Clin. Invest. 118, 1502-1510.